EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Aloesin ameliorates hypoxic‐ischemic brain damage in neonatal mice by suppressing TLR4‐mediated neuroinflammation

Liping Chen iD, Siqing Xiong, Xiaofan Zhou, Qiang Fu

Immunity, Inflammation and Disease · 2024

DOI: 10.1002/iid3.1320 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2024. Verfasst von Liping Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, Ji'an Central People's Hospital, Ji'an, Jiangxi Province, China. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, Hypoxia-Ischemia, Brain, Animals, Newborn, Neuroprotective Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Science and Technology Planed Projects of Jiangxi Provincial Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

At present, neonatal hypoxic‐ischemic encephalopathy (HIE), especially moderate to severe HIE, is a challenging disease for neonatologists to treat, and new alternative/complementary treatments are urgently needed. The neuroinflammatory cascade triggered by hypoxia‐ischemia (HI) insult is one of the core pathological mechanisms of HIE. Early inhibition of neuroinflammation provides long‐term neuroprotection. Plant‐derived monomers have impressive anti‐inflammatory effects. Aloesin (ALO) has been shown to have significant anti‐inflammatory and antioxidant effects in diseases such as ulcerative colitis, but its role in HIE is unclear. To this end, we conducted a series of experiments to explore the potential mechanism of ALO in preventing and treating brain damage caused by HI insult. Materials and Methods Hypoxic‐ischemic brain damage (HIBD) was induced in 7‐day‐old Institute of Cancer Research (ICR) mice, which were then treated with 20 mg/kg ALO. The neuroprotective effects of ALO on HIBD and the underlying mechanism were evaluated through neurobehavioral testing, infarct size measurement, apoptosis detection, protein and messenger RNA level determination, immunofluorescence, and molecular docking.

Results

ALO alleviated the long‐term neurobehavioral deficits caused by HI insult; reduced the extent of cerebral infarction; inhibited cell apoptosis; decreased the levels of the inflammatory factors interleukin (IL)‐1β, IL‐6, and tumor necrosis factor‐α; activated microglia and astrocytes; and downregulated the protein expression of members in the TLR4 signaling pathway. In addition, molecular docking showed that ALO can bind stably to TLR4.

Conclusion

ALO ameliorated HIBD in neonatal mice by inhibiting the neuroinflammatory response mediated by TLR4 signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 4Hypoxia-Ischemia, BrainAnimals, NewbornNeuroprotective AgentsNeuroinflammatory DiseasesAnimalsMiceMice, Inbred ICRDisease Models, AnimalSignal TransductionApoptosisAnti-Inflammatory AgentsMolecular Docking Simulation

Stichwörter der Autor:innen

AloesinTLR4hypoxic‐ischemic brain damageneuroinflammation

Substanzen

Toll-Like Receptor 4Tlr4 protein, mouseNeuroprotective AgentsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Rehabilitation Medicine, Ji'an Central People's Hospital, Ji'an, Jiangxi Province, China.
  • Department of Urinary Surgery, Ji'an Central People's Hospital, Ji'an, Jiangxi Province, China.
  • Department of Respiratory and Critical Care Medicine, Ji'an Central People's Hospital, Ji'an, Jiangxi Province, China.
  • Health Science Center, Jinggangshan University, Ji'an, Jiangxi Province, China.

ORCID-Profile: Liping Chen

Förderung

  • The Science and Technology Planed Projects of Jiangxi Provincial Health Commission

Zitieren

APA

Chen, L., Xiong, S., Zhou, X., & Fu, Q. (2024). Aloesin ameliorates hypoxic‐ischemic brain damage in neonatal mice by suppressing TLR4‐mediated neuroinflammation. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.1320

Vancouver

Chen L, Xiong S, Zhou X, Fu Q. Aloesin ameliorates hypoxic‐ischemic brain damage in neonatal mice by suppressing TLR4‐mediated neuroinflammation. Immunity, Inflammation and Disease. 2024. doi:10.1002/iid3.1320

BibTeX
@article{Chen2024,
  author = {Chen, Liping and Xiong, Siqing and Zhou, Xiaofan and Fu, Qiang},
  title = {Aloesin ameliorates hypoxic‐ischemic brain damage in neonatal mice by suppressing TLR4‐mediated neuroinflammation},
  journal = {Immunity, Inflammation and Disease},
  year = {2024},
  doi = {10.1002/iid3.1320}
}
Kostenlos starten →